This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
PAVmed Inkomsten in het verleden
Verleden criteriumcontroles 0/6
PAVmed's earnings have been declining at an average annual rate of -36.5%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 75.9% per year.
Belangrijke informatie
-36.5%
Groei van de winst
-5.6%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 4.3% |
Inkomstengroei | 75.9% |
Rendement op eigen vermogen | n/a |
Nettomarge | -4,679.7% |
Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe PAVmed geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 23 | 2 | -71 | 52 | 18 |
30 Jun 23 | 1 | -79 | 56 | 21 |
31 Mar 23 | 1 | -90 | 62 | 24 |
31 Dec 22 | 0 | -89 | 60 | 26 |
30 Sep 22 | 1 | -86 | 57 | 26 |
30 Jun 22 | 1 | -72 | 50 | 25 |
31 Mar 22 | 1 | -58 | 43 | 22 |
31 Dec 21 | 1 | -51 | 34 | 20 |
30 Sep 21 | 0 | -42 | 26 | 17 |
30 Jun 21 | 0 | -35 | 20 | 14 |
31 Mar 21 | 0 | -30 | 15 | 12 |
31 Dec 20 | 0 | -35 | 12 | 11 |
30 Sep 20 | 0 | -32 | 11 | 10 |
30 Jun 20 | 0 | -30 | 10 | 8 |
31 Mar 20 | 0 | -28 | 9 | 8 |
31 Dec 19 | 0 | -17 | 8 | 7 |
30 Sep 19 | 0 | -17 | 7 | 6 |
30 Jun 19 | 0 | -17 | 7 | 5 |
31 Mar 19 | 0 | -19 | 7 | 5 |
31 Dec 18 | 0 | -19 | 6 | 4 |
30 Sep 18 | 0 | -12 | 6 | 3 |
30 Jun 18 | 0 | -14 | 6 | 3 |
31 Mar 18 | 0 | -10 | 5 | 3 |
31 Dec 17 | 0 | -10 | 5 | 3 |
30 Sep 17 | 0 | -12 | 5 | 3 |
30 Jun 17 | 0 | -9 | 5 | 3 |
31 Mar 17 | 0 | -9 | 5 | 2 |
31 Dec 16 | 0 | -6 | 4 | 2 |
30 Sep 16 | 0 | -5 | 4 | 1 |
30 Jun 16 | 0 | -3 | 3 | 1 |
31 Mar 16 | 0 | -2 | 2 | 1 |
31 Dec 15 | 0 | -2 | 1 | 0 |
Kwaliteitswinsten: 1P50 is currently unprofitable.
Groeiende winstmarge: 1P50 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 1P50 is unprofitable, and losses have increased over the past 5 years at a rate of 36.5% per year.
Versnelling van de groei: Unable to compare 1P50's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: 1P50 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Rendement op eigen vermogen
Hoge ROE: 1P50's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.